Bronchopulmonary Dysplasia (BPD) Imaging

Back

Practice Essentials

Bronchopulmonary dysplasia (BPD) is a chronic pulmonary disorder that results from the use of high positive-pressure mechanical ventilation and high concentration oxygen in neonates with respiratory distress syndrome (RDS) (see the image below). This condition is defined as oxygen dependence at 28 days and is pathologically characterized by inflammation, mucosal necrosis, fibrosis, and smooth muscle hypertrophy of the airways.[1, 2]  Radiography is the mainstay imaging test for the diagnosis of BPD, but high-resolution computed tomography (HRCT) may be useful in the further evaluation of BPD.[3, 4, 5, 6, 7, 8]

Because of new strategies over the past 20 years, more very low birth weight infants have survived, resulting in a change in the characteristics of BPD. The so-called “new BPD” displays much less airway damage and alveolar septal fibrosis as compared to previous cases of BPD.[9]  BPD remains the most common complication in premature infants, affecting approximately 20,000 to 30,000 infants a year in the United States.[10, 11, 12, 13, 14, 15]

The incidence of BPD varies between 5 and 40%, and is common in preterm infants—10% of infants weighing less than 1500 g and 20% of those weighing less than 1000 g develop this condition. With advances in therapy, BPD is currently uncommon after 30 weeks' gestation or in infants weighing more than 1200 g.[16, 17, 18, 19]



View Image

Chest radiograph of an infant with bronchopulmonary dysplasia.

Imaging modalities

Radiography is the mainstay imaging test for the diagnosis of bronchopulmonary dysplasia.[4, 5, 20]  Four stages of radiographic changes of BPD have been described: stage I, which is RDS seen in the first week; stage II, which includes generalized haziness and plethora in the second week; stage III, which involves cystic changes and stranding in the third week; and stage IV, which is characterized by hyperinflation,[21]  extensive stranding, and an enlarged heart in the fourth week.

High-resolution CT (HRCT) scans are rarely needed in the further evaluation of bronchopulmonary dysplasia. When used, however, HRCT scans show different findings depending on the stage of disease. In stage 1, HRCT scans show changes of respiratory distress syndrome, pneumothorax, and pulmonary interstitial emphysema. In stage 2, interlobular septal thickening is the most common finding. Stage 3 is characterized by linear atelectasis and fibrotic changes.[22, 23, 24, 25]

Although the radiation burden of conventional thoracic CT is greater than that of chest radiography, technological advances such as rotational tube current modulation and adaptive array, as well as dose-optimization programs, have resulted in a significant reduction in CT radiation. In addition, spiral/volumetric acquisitions can produce continuous volumetric data sets with isotropic voxels (three-dimensional pixels) that allow multiplanar reconstruction. Major improvements in scanning children include faster tube rotation speeds, greater numbers of detectors and dual source systems, and immobilization devices to reduce the effects of body movements in newborns. Even at high heart rates typical in neonates, high-pitch CT has been able to demonstrate, in acceptable detail, small, fast-moving structures, such as the pulmonary veins.[26, 27, 28, 29]

Although nuclear medicine studies are nonspecific investigations and not useful in diagnosing BPD, perfusion scintigraphic findings are well correlated with the clinical severity of the disease. Marked ventilation-perfusion mismatch due to the destruction of the lung is observed. Another finding is the loss of gravity-dependent flow distribution. 

Lung ultrasound scores have been shown to allow the monitoring of lung aeration and function in extremely preterm infants,[30]  Semple et al note, however, that lung ultrasonography does not constitute a potential replacement for plain radiography, because central pathology and important complications arising from misplaced support apparatus or air leaks can be completely missed on ultrasound.[26]

In a study by Alonso-Ojembarrena et al of 59 preterm very low birth weight infants, a lung ultrasound (LUS) score of 5 or above had a sensitivity of 71% and a specificity of 80% for predicting BPD 1 week after birth. At 2 weeks, the sensitivity increased to 74% and the specificity to 100%. An LUS score of 4 or above 4 weeks after birth predicted moderate to severe BPD with a sensitivity of 100% and a specificity of 80%.[31]  A study by Oulego-Erroz et al of 42 preterm infants on the 7th day of life found that an LUS score of 8 or more predicted moderate to severe BPD with a sensitivity of 93% and a specificity of 91%.[32]  

Hochino et al found that LUS with whole chest scanning helped predict respiratory outcome in patients with BPD. LUS at 28 days of life predicted moderate to severe BPD with an area under the curve of 0.95 (95% confidence interval: 0.91-0.99) and home oxygen therapy with an area under the curve of 0.95 (95% confidence interval: 0.81-1.0).[33]

Stages of BPD

BPD is believed to be a disease of scarring and repair. Although the exact pathophysiology is still unclear, 4 stages in the development of BPD are identified, as follows:

Long-term changes

Pathologic changes in long-term survival are interstitial fibrosis, hyperinflation, reduced number of alveoli, reduction in alveolar surface area, arrested acinar development, pseudofissures, airway hyperplasia, and atelectasis. Sequelae of chronic lung disease include pulmonary arterial hypertension and right-sided cardiac failure.[18] Tracheobronchomegaly, tracheomalacia, and ciliary dysfunction are associated findings.

Differential diagnosis and other problems to be considered

BPD should be differentiated from chronic lung disease, which is oxygen dependence at 28 days or 36 weeks' gestation and which is also seen in patients ventilated because of apnea or meconium aspiration. Persistent pulmonary hypertension of the newborn (PPHN) is another consideration.

Infants with Wilson-Mikity syndrome, a chronic lung disease that occurs in 2% of infants who are born preterm with a low birth weight (ie, those without a history of high-pressure ventilation or exposure to high oxygen concentrations), do not develop respiratory distress syndrome.[18, 19] This syndrome is commonly seen between 1 and 2 months of age, and most cases slowly resolve. Chest radiographic findings are normal in the first week, but after that time, they are similar to those of BPD, with hyperinflation, stranding, streaky infiltrates, and cystic changes. Radiographic changes persist for a few months to years after clinical findings resolve.

The differential diagnosis should also include the following:

Radiography

Radiography is the mainstay imaging test for the diagnosis of bronchopulmonary dysplasia (BPD) (see the following image).[20, 4, 5]  Four stages of radiographic changes of BPD have been described: stage I, which is respiratory distress syndrome seen in the first week; stage II, which includes generalized haziness and plethora in the second week; stage III, which involves cystic changes and stranding in the third week; and stage IV, which is characterized by hyperinflation,[21]  extensive stranding, and an enlarged heart in the fourth week.



View Image

Chest radiograph of an infant with bronchopulmonary dysplasia.

Findings can also be described according to the original 4 stages of BPD that Northway et al established[34] :

By day 3, radiographic changes can be seen as pulmonary edema. By 1 week, images may show interstitial edema, septal lines, and loss of the clear outlines of pulmonary vessels. Strandlike opacities may be due to lymphatic engorgement or atelectasis. Cardiomegaly may be seen if patent ductus arteriosus or fluid overload is present. The changes are early and severe if they are caused by infections. Infection and fluid overload are difficult to distinguish on radiographs alone. By the third week, fibrosis and/or atelectasis may be observed in upper lobes.

Hyperinflation can produce right ventricular enlargement, prominent hila due to pulmonary arteries, and pruning of the peripheral pulmonary arteries. In rare cases, the trachea is enlarged and softened.

Long-term changes

The incidence of long-term changes is due to increasing survival of low-birth-weight infants. Radiographic changes gradually clear with age, and in some individuals, complete clearing is observed. Two thirds of patients have some remnant change, such as linear shadows and strands due to fibrosis or pleural pseudofissures, which persists into middle childhood

The anteroposterior (AP) diameter of the chest can be narrow. Air trapping increases the AP diameter of the chest. Hyperexpansion due to scarring and/or hyperplasia of mature alveoli, alveolar-wall distention, or diminished bronchial diameter is seen. Focal hyperlucent areas can be present because of expiratory air trapping.

Development of viral and other bacterial pneumonias can interrupt clearing of the radiographic findings. These pneumonias produce consolidation and atelectatic changes.

The changes can be classified as type I or II  and may resolve over months to years; the lungs can become normal. Type I is hazy shadowing without air bronchograms or focal hyperinflation. Type II is less common than type I and is characterized by large-volume lungs and coarse, linear shadows due to scarring and cyst formation.

Modern treatment produces only 2 types of CLD: classic or severe, which can be new or mild. The appearance depends on a balance between inflammation, injury, healing, growth and maturation, prematurity, low birth weight, neonatal respiratory illness, and treatment.

Degree of confidence

Radiographic findings are reliable indicators of future respiratory insufficiency in BPD. In a study by Palta et al, radiographic evidence was more predictive of long-term respiratory outcome than other commonly used criteria, although all criteria were significantly associated with all the outcomes. The investigators assessed the (1) use of supplemental oxygen on day 30 of life, (2) application of comprehensive BPD-severity score at 25-35 days of life developed by a clinician panel, (3) use of supplemental oxygen on day 30 of life with radiographic evidence consistent with BPD at 25-35 days of life, (4) radiographic evidence consistent with BPD alone, and (5) use of supplemental oxygen at 36 weeks' postconceptional age. The criteria were assessed for the outcomes of bronchodilator or steroid use during the first 2 years of life, diagnosis of asthma, and hospitalizations for respiratory causes up to age 5 years.[35]

The radiographic appearance of BPD in middle childhood is described by Griscom et al.[36]  However, in a study by Moya et al, using chest radiographs for the prediction of BPD did not have interobserver reliability, except at the 2 extremes of the disease.[6]

The presence of radiographic abnormalities 2 weeks after the onset of respiratory distress syndrome is usually due to BPD. Conditions that mimic the radiologic appearances of BPD are cardiac failure, pulmonary edema, infections, and pulmonary interstitial emphysema.

Computed Tomography

HRCT scans are rarely needed in the further evaluation of bronchopulmonary dysplasia. When used, however, HRCT scans show different findings depending on the stage of disease.[22, 23]

Stages of BPD on HRCT scans

In stage 1, HRCT scans show changes of respiratory distress syndrome, pneumothorax, and pulmonary interstitial emphysema.

In stage 2, interlobular septal thickening is the most common finding. On expiratory scans, air trapping is well depicted as abnormal lucencies. Hyperinflation, areas of atelectasis, consolidation, prominent pulmonary arteries, and an enlarged heart are other features. In severe disease, scans show marked distortion of the lung parenchyma, large cysts, coarse fibrosis, and pulmonary hypertension.

Stage 3 is characterized by linear atelectasis and fibrotic changes, as well as gradual clearing of areas of attenuation.

In the chronic stages in long-term survivors, HRCT can be completely normal, but signs such as the following are often present[37, 38] :

Advances in CT in neonates

Although the radiation burden of conventional thoracic CT is greater than that of chest radiography, technological advances such as rotational tube current modulation and adaptive array, as well as dose-optimization programs, have resulted in a significant reduction in CT radiation. In addition, spiral/volumetric acquisitions can produce continuous volumetric data sets with isotropic voxels (three-dimensional pixels) that allow multiplanar reconstruction. Major improvements in scanning children include faster tube rotation speeds, greater numbers of detectors and dual source systems, and immobilization devices to reduce the effects of body movements in newborns. Even at high heart rates typical in neonates, high-pitch CT has been able to demonstrate, in acceptable detail, small, fast-moving structures, such as the pulmonary veins.[26, 27, 28, 29]

Author

Prabhakar Rajiah, MD, MBBS, FRCR, Associate Professor, Department of Radiology, Division of Cardiothoracic Imaging, Associate Director of Computer Tomography (CT) and Magnetic Resonance Imaging (MRI), UT Southwestern Medical Center

Disclosure: Nothing to disclose.

Specialty Editors

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand

Disclosure: Nothing to disclose.

David A Stringer, MBBS, FRCR, FRCPC, Professor, National University of Singapore; Head, Diagnostic Imaging, KK Women's and Children's Hospital, Singapore

Disclosure: Nothing to disclose.

Chief Editor

Eugene C Lin, MD, Attending Radiologist, Teaching Coordinator for Cardiac Imaging, Radiology Residency Program, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Fredric A Hoffer, MD, FSIR, Affiliate Professor of Radiology, University of Washington School of Medicine; Member, Quality Assurance Review Center

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of eMedicine gratefully acknowledge the contributions of previous coauthor Dr Biswaranjan Banerjee to the development and writing of this article.

References

  1. Walkup LL, Woods JC. Newer Imaging Techniques for Bronchopulmonary Dysplasia. Clin Perinatol. 2015 Dec. 42 (4):871-87. [View Abstract]
  2. Bancalari E. Neonatal chronic lung disease. In: Neonatal Perinatal Medicine: Diseases of the Fetus and Infant. 6th ed. 1997: 1082.
  3. Aukland SM, Rosendahl K, Owens CM, Fosse K, Eide GE, Halvorsen T. Neonatal bronchopulmonary dysplasia predicts abnormal pulmonary HRCT in long term survivors of extreme preterm birth. Thorax. 2009 Jan 21. [View Abstract]
  4. May C, Prendergast M, Salman S, Rafferty GF, Greenough A. Chest radiograph thoracic areas and lung volumes in infants developing bronchopulmonary dysplasia. Pediatr Pulmonol. 2009 Jan. 44(1):80-5. [View Abstract]
  5. Czarnecki ŁM. Assessment of chest X-ray images in newborns with respiratory disorders. Kardiochir Torakochirurgia Pol. 2015 Mar. 12 (1):83-6. [View Abstract]
  6. Moya MP, Bisset GS, Auten RL, et al. Reliability of CXR for the diagnosis of bronchopulmonary dysplasia. Pediatr Radiol. 2001 May. 31(5):339-42. [View Abstract]
  7. Walkup LL, Tkach JA, Higano NS, Thomen RP, Fain SB, Merhar SL, et al. Quantitative Magnetic Resonance Imaging of Bronchopulmonary Dysplasia in the Neonatal Intensive Care Unit Environment. Am J Respir Crit Care Med. 2015 Nov 15. 192 (10):1215-22. [View Abstract]
  8. Vanhaverbeke K, Van Eyck A, Van Hoorenbeeck K, et al. Lung imaging in bronchopulmonary dysplasia: a systematic review. Respir Med. 2020 Sep. 171:106101. [View Abstract]
  9. Sahni M, Mowes AK. Bronchopulmonary Dysplasia. 2020 Jan. [View Abstract]
  10. Shepherd EG, De Luca D. New Imaging Tools Allow Bronchopulmonary Dysplasia to Enter the Age of Precision Medicine. Am J Respir Crit Care Med. 2020 Oct 1. 202 (7):924-926. [View Abstract]
  11. Lapcharoensap W, Gage SC, Kan P, et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr. 2015 Feb. 169 (2):e143676. [View Abstract]
  12. Thébaud B, Goss KN, Laughon M, et al. Bronchopulmonary dysplasia. Nat Rev Dis Primers. 2019 Nov 14. 5 (1):78. [View Abstract]
  13. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001 Jun. 163 (7):1723-9. [View Abstract]
  14. Murthy K, Porta NFM, Lagatta JM, et al. Inter-center variation in death or tracheostomy placement in infants with severe bronchopulmonary dysplasia. J Perinatol. 2017 Jun. 37 (6):723-727. [View Abstract]
  15. Slaughter JL, Pakrashi T, Jones DE, South AP, Shah TA. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol. 2011 Oct. 31 (10):635-40. [View Abstract]
  16. Srisuparp P, Marks JD, Khoshnood B, Schreiber MD. Predictive power of initial severity of pulmonary disease for subsequent development of bronchopulmonary dysplasia. Biol Neonate. 2003. 84(1):31-6. [View Abstract]
  17. Lefkowitz W, Rosenberg SH. Bronchopulmonary dysplasia: pathway from disease to long-term outcome. J Perinatol. 2008 Dec. 28(12):837-40. [View Abstract]
  18. Eber E, Zach MS. Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax. 2001 Apr. 56(4):317-23.
  19. Glowacka E, Lis G. [Bronchopulmonary dysplasia - early and long-term pulmonary sequelae.]. Pneumonol Alergol Pol. 2008. 76(6):437-445. [View Abstract]
  20. Trotter C, Carey BE. Radiology basics, II: RDS and BPD. Neonatal Netw. 2000 Apr. 19(3):37-40. [View Abstract]
  21. Azizkhan RG, Grimmer DL, Askin FB, et al. Acquired lobar emphysema (overinflation): clinical and pathological evaluation of infants requiring lobectomy. J Pediatr Surg. 1992 Aug. 27(8):1145-51; discussion 1151-2. [View Abstract]
  22. Aquino SL, Schechter MS, Chiles C, et al. High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia. AJR Am J Roentgenol. 1999 Oct. 173(4):963-7. [View Abstract]
  23. van Mastrigt E, Logie K, Ciet P, Reiss IK, Duijts L, Pijnenburg MW, et al. Lung CT imaging in patients with bronchopulmonary dysplasia: A systematic review. Pediatr Pulmonol. 2016 May 5. [View Abstract]
  24. Sung TJ, Hwang SM, Kim MY, Park SG, Choi KY. Relationship between clinical severity of "new" bronchopulmonary dysplasia and HRCT abnormalities in VLBW infants. Pediatr Pulmonol. 2018 Oct. 53 (10):1391-1398. [View Abstract]
  25. Ronkainen E, Perhomaa M, Mattila L, Hallman M, Dunder T. Structural Pulmonary Abnormalities Still Evident in Schoolchildren with New Bronchopulmonary Dysplasia. Neonatology. 2018. 113 (2):122-130. [View Abstract]
  26. Semple T, Akhtar MR, Owens CM. Imaging Bronchopulmonary Dysplasia-A Multimodality Update. Front Med (Lausanne). 2017. 4:88. [View Abstract]
  27. van Mastrigt E, Logie K, Ciet P, et al. Lung CT imaging in patients with bronchopulmonary dysplasia: A systematic review. Pediatr Pulmonol. 2016 Sep. 51 (9):975-86. [View Abstract]
  28. Sriharan M, Lazoura O, Pavitt CW, et al. Evaluation of High-Pitch Ungated Pediatric Cardiovascular Computed Tomography for the Assessment of Cardiac Structures in Neonates. J Thorac Imaging. 2016 May. 31 (3):177-82. [View Abstract]
  29. Shi JW, Xu DF, Dai HZ, Shen L, Ji YD. Evaluation of chest CT scan in low-weight children with ultralow tube voltage (70 kVp) combined with Flash scan technique. Br J Radiol. 2016. 89 (1059):20150184. [View Abstract]
  30. Loi B, Vigo G, Baraldi E, Raimondi F, Carnielli VP, Mosca F, et al. Lung Ultrasound to Monitor Extremely Preterm Infants and Predict BPD: Multicenter Longitudinal Cohort Study. Am J Respir Crit Care Med. 2020 Dec 22. [View Abstract]
  31. Alonso-Ojembarrena A, Lubián-López SP. Lung ultrasound score as early predictor of bronchopulmonary dysplasia in very low birth weight infants. Pediatr Pulmonol. 2019 Sep. 54 (9):1404-1409. [View Abstract]
  32. Oulego-Erroz I, Alonso-Quintela P, Terroba-Seara S, Jiménez-González A, Rodríguez-Blanco S. Early assessment of lung aeration using an ultrasound score as a biomarker of developing bronchopulmonary dysplasia: a prospective observational study. J Perinatol. 2020 Jul 14. [View Abstract]
  33. Hoshino Y, Arai J, Miura R, et al. Lung Ultrasound for Predicting the Respiratory Outcome in Patients with Bronchopulmonary Dysplasia. Am J Perinatol. 2020 Dec 29. [View Abstract]
  34. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16. 276(7):357-68. [View Abstract]
  35. Palta M, Sadek M, Barnet JH, et al. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project. J Pediatr. 1998 Jan. 132(1):57-63. [View Abstract]
  36. Griscom NT, Wheeler WB, Sweezey NB, et al. Bronchopulmonary dysplasia: radiographic appearance in middle childhood. Radiology. 1989 Jun. 171(3):811-4. [View Abstract]
  37. Howling SJ, Northway WH, Hansell DM, et al. Pulmonary sequelae of bronchopulmonary dysplasia survivors: high-resolution CT findings. AJR Am J Roentgenol. 2000 May. 174(5):1323-6. [View Abstract]
  38. Oppenheim C, Mamou-Mani T, Sayegh N, et al. Bronchopulmonary dysplasia: value of CT in identifying pulmonary sequelae. AJR Am J Roentgenol. 1994 Jul. 163(1):169-72. [View Abstract]
  39. Abdelmawla M, Louis D, Narvey M, Elsayed Y. A Lung Ultrasound Severity Score Predicts Chronic Lung Disease in Preterm Infants. Am J Perinatol. 2019 Nov. 36 (13):1357-1361. [View Abstract]
  40. Carey BE, Trotter C. Bronchopulmonary dysplasia. Neonatal Netw. 2000 Apr. 19(3):45-9. [View Abstract]
  41. Davis JM, Rosenfield WN. Chronic lung disease. Avery's Diseases of the Newborn. 7th ed. Philadelphia, Pa: Harcourt Brace Jovanovich;. 1998: 509-31.
  42. Northway WH. An introduction to bronchopulmonary dysplasia. Clin Perinatol. 1992 Sep. 19(3):489-95. [View Abstract]
  43. Korones SB. Complications of bronchopulmonary dysplasia, air leak syndromes, and retinopathy of prematurity. In: Assisted Ventilation of the Newborn. 3rd ed. Philadelphia, Pa: WB Saunders;. 1996.
  44. Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988 Oct. 82(4):527-32. [View Abstract]
  45. Slovis TL. Congenital and acquired lesions (most causing respiratory distress). In: Caffey's Pediatric Diagnostic Imaging. Vol 1. 10th ed. St Louis, Mo: Mosby/Elsevier Science;. 2004: 95-8.

Chest radiograph of an infant with bronchopulmonary dysplasia.

Chest radiograph of an infant with bronchopulmonary dysplasia.

Chest radiograph of an infant with bronchopulmonary dysplasia.